The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Management strategies and patient outcomes among LPC patients with persistently positive PSA after RP.
 
Shawn Malone
Honoraria - Abbvie; Astellas Pharma; AstraZeneca; Bayer; Janssen; Knight Pharmaceuticals; sumitomo pharma; Tolmar
 
Christopher Wallis
Honoraria - Abbvie; Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; EMD Serono; Haymarket Medical Education; Knight Therapeutics; Merck; Tersera; Tolmar
Consulting or Advisory Role - Janssen Oncology; Nanostics; Precision Point Specialty; Sesen Bio
Research Funding - Bayer (Inst); Knight Therapeutics (Inst); Tolmar (Inst)
Travel, Accommodations, Expenses - Janssen; Knight Therapeutics; Knight Therapeutics; Tersera; Tolmar; Verity Pharmaceuticals
 
Ilias Cagiannos
Honoraria - Abbvie; Bayer; Janssen Oncology; Knight Pharmaceuticals; Tersera; Tolmar
Consulting or Advisory Role - Abbvie; Bayer; Knight Pharmaceuticals
Speakers' Bureau - Abbvie; Tersera
Research Funding - Tolmar
Travel, Accommodations, Expenses - Tersera
 
Robert Hamilton
Honoraria - Astellas Pharma; Bayer; Janssen; Knight Pharmaceuticals; Merck; Novartis; Tersera; Tolmar
Research Funding - Bayer; Janssen; Novartis
Travel, Accommodations, Expenses - Janssen; Tolmar
 
Naveen Basappa
Stock and Other Ownership Interests - illumiSonics
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Eisai; Ipsen; Janssen; Merck; Pfizer; Seagen; Takeda
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; EMD Serono; Ipsen; Janssen; Merck; Pfizer; Seagen
Research Funding - Ipsen (Inst)
Travel, Accommodations, Expenses - Eisai; Ipsen; Johnson & Johnson/Janssen; Pfizer
 
Cristiano Ferrario
Honoraria - AstraZeneca; Bayer; Janssen Oncology; Merck; Novartis; Pfizer; Roche Canada
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Merck; Novartis; Roche
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Janssen Oncology (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen
 
Geoffrey Gotto
Honoraria - Astellas Pharma; AstraZeneca; Bayer; EMD Serono; Ferring; Janssen; McKesson; Merck; Pfizer; Sanofi; Tolmar
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; EMD Serono; Ferring; Janssen; McKesson; Merck; Pfizer; Sanofi; Tolmar
Research Funding - Janssen
Expert Testimony - Janssen
Travel, Accommodations, Expenses - Janssen
 
Ricardo Fernandes
Honoraria - Bayer; Bayer; Eisai; EMD Serono; Ipsen; Merck; Pfizer
Consulting or Advisory Role - Bayer; Bayer; Janssen; Janssen; Janssen; Janssen; Janssen; Merck; Novartis Canada Pharmaceuticals Inc; Pan-Canadian Oncology Drug Review (pCODR); Pfizer
Travel, Accommodations, Expenses - Janssen; Janssen
 
Tamim Niazi
Stock and Other Ownership Interests - Knight Pharmaceuticals
Honoraria - Abbvie; Astellas Pharma; Bayer; Janssen Oncology; Merck; Sanofi; Tersera; Tolmar
Consulting or Advisory Role - Abbvie; AstraZeneca Canada; Bayer; Janssen Oncology; Sanofi; Tersera
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Sanofi (Inst); Tersera (Inst)
Travel, Accommodations, Expenses - Janssen Oncology; Sanofi; Tersera
 
Chris Morash
Stock and Other Ownership Interests - KVR Pharmaceuticals
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Janssen Oncology; Knight Pharmaceuticals; Sumitomo Pharma Oncology; Tersera; Tolmar
 
Ricardo Rendon
Stock and Other Ownership Interests - Myovant Sciences
Honoraria - Astellas Pharma; Bayer; Janssen; Sanofi
Speakers' Bureau - Astellas Pharma; Bayer; Janssen
 
Fred Saad
Honoraria - Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bayer; BMS; Janssen Oncology; Knight Therapeutics; Merck; Myovant Sciences; Novartis; Pfizer; Sanofi; Tolmar
Consulting or Advisory Role - Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca/MedImmune; Bayer; Janssen Oncology; Knight Therapeutics; Myovant Sciences; Novartis; Pfizer; Sanofi; Tolmar
Research Funding - Advanced Accelerator Applications (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
 
Sebastien Hotte
Honoraria - Advanced Accelerator Applications/Novartis; Astellas Scientific and Medical Affairs Inc; Bayer
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen; Merck; Novartis Canada Pharmaceuticals Inc; Pfizer
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Ayala Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); ESSA (Inst); Janssen Oncology (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst); SignalChem (Inst)
 
Brendan Osborne
Employment - Janssen
Stock and Other Ownership Interests - Janssen
Travel, Accommodations, Expenses - Janssen
 
Katherine Chan
Employment - Johnson & Johnson/Janssen
 
Anousheh Zardan
Employment - Janssen; Johnson and Johnson Innovative Medicine
 
Bobby Shayegan
Consulting or Advisory Role - Abbvie; Astellas Pharma; Bayer; Janssen Oncology; Knight Pharmaceuticals; Novartis Canada Pharmaceuticals Inc; Novartis Canada Pharmaceuticals Inc; Tersera; Tolmar